Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop

Yichao Hua, Gerlanda Vella, Florian Rambow, Elizabeth Allen, Asier Antoranz Martinez, Marie Duhamel, Akira Takeda, Sirpa Jalkanen, Steffie Junius, Ann Smeets, David Nittner, Stefanie Dimmeler, Thomas Hehlgans, Adrian Liston, Francesca Maria Bosisio, Giuseppe Floris, Damya Laoui, Maija Hollmén, Diether Lambrechts, Pascal MerchiersJean-Christophe Marine, Susan Schlenner, Gabriele Bergers

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
22 Downloads (Pure)

Abstract

(Cancer Cell 40, 1600–1618; December 12, 2022) In this article, the authors demonstrated that antiangiogenic immunotherapies differentiate postcapillary venules into high-endothelial venules (HEVs) that foster permissive TCF1 + T lymphocyte niches. In the introduction, they mistakenly stated that HEVs express L-Selectin/CD62L, while HEVs express the sulphated and glycosylated ligands for L-Selectin/CD62L. The original article has been corrected online. The authors regret this error and apologize for any confusion this might have caused.

Original languageEnglish
Pages (from-to)226-226
Number of pages1
JournalCancer Cell
Volume41
Issue number1
DOIs
Publication statusPublished - 9 Jan 2023

Bibliographical note

Publisher Copyright:
© 2022 The Author(s)

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Fingerprint

Dive into the research topics of 'Correction: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop'. Together they form a unique fingerprint.

Cite this